Showing 1 - 10 of 22
We begin by documenting trends in the changing geographical location of clinical trials for new medicines since 2002, away from Western Europe and Canada, and towards Eastern Europe, Latin America and Asia. We then develop a framework for modeling the factors affecting the globalization of...
Persistent link: https://www.econbiz.de/10014049979
We estimate hedonic price indexes for clinical trial research, an important component of biomedical R&D, using a large sample of agreements between trial sponsors and clinical investigators obtained from Medidata Solutions Worldwide Inc. Nominal prices measured as total grant cost per patient...
Persistent link: https://www.econbiz.de/10013064303
Persistent link: https://www.econbiz.de/10009735806
We estimate hedonic price indexes for clinical trial research, an important component of biomedical R&D, using a large sample of agreements between trial sponsors and clinical investigators obtained from Medidata Solutions Worldwide Inc. Nominal prices measured as total grant cost per patient...
Persistent link: https://www.econbiz.de/10012459743
Persistent link: https://www.econbiz.de/10003326180
Persistent link: https://www.econbiz.de/10000880078
Persistent link: https://www.econbiz.de/10001197904
This paper presents the results of a study of the determinants of research productivity in the pharmaceutical industry. Using disaggregated, internal firm data at the research program level from ten major pharmaceutical companies, we find no evidence of increasing returns to scale at either the...
Persistent link: https://www.econbiz.de/10013239955
Persistent link: https://www.econbiz.de/10010416770
Persistent link: https://www.econbiz.de/10010416907